Cite
HARVARD Citation
Kamen, D. et al. (2022). Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus science & medicine. 9 (1), p. . [Online].